|
SAS provides a centralized, integrated solution for managing, analyzing, reporting and reviewing clinical research information. This solution enables life sciences organizations to make informed business decisions with confidence, to assess the safety and efficacy of research compounds more effectively, to collaborate across trials, phases and therapeutic areas successfully, and ultimately get better products to market faster.
Available drug discovery and development solution from SAS
|
SAS® Drug Development provides an analysis and reporting solution that enables global collaboration with complete compliance and control.
|
How SAS is different
Only SAS provides a secure, collaborative framework that puts controlled power into the hands of researchers who need it. The result is greater productivity and efficiency in these areas:
- Integration. Efficiently integrate and manage data from a wide range of sources – such as electronic data capture (EDC) systems, in-house clinical data management systems (CDMS), labs and contract research organizations (CROs) – while leveraging investments in existing systems and resources.
- Analysis and reporting. Accurately assess and report on study data in a timely manner. Efficiently generate presentation-ready statistical summaries of clinical trials data and easily share results with researchers or reviewers on demand.
- Discovery. Use your growing research information repository to rapidly investigate critical drug safety issues, pursue new marketing claims and explore potential product-line extensions.
- Regulatory compliance. Document research content via integrated processes that provide versioning, audit trails and electronic signatures, as well as fully describing the relationships between all process inputs, transformations, analyses and results.
|